A technical guide for laboratory researchers conducting KPV 5mg reconstitution, solubility testing, and liquid storage protocols. This document provides precise reconstitution calculations, solvent compatibility data, and physical handling procedures for in vitro and animal models.
A technical guide for laboratory researchers conducting KPV 5mg reconstitution, solubility testing, and liquid storage protocols. This document provides precise reconstitution calculations, solvent compatibility data, and physical handling procedures for in vitro and animal models.
For standard KPV 5mg reconstitution, introduce 2.0 mL of bacteriostatic water or sterile phosphate-buffered saline (PBS) into the vial under aseptic laboratory conditions, yielding a stock concentration of 2.5 mg/mL (2,500 µg/mL). Gently swirl the vial without vortexing until the lyophilized tripeptide cake completely dissolves into a clear, colorless solution for in vitro assays or animal model administration.
Researchers seeking specific working concentrations can adjust the diluent volume according to standardized laboratory calculations. Adding 5.0 mL of diluent produces a 1.0 mg/mL concentration, while 1.0 mL yields a concentrated 5.0 mg/mL stock solution. Always allow the KPV 5mg lyophilized vial to equilibrate to room temperature prior to reconstituting to prevent moisture condensation and peptide degradation.
KPV is a synthetic tripeptide consisting of the C-terminal amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). It represents the C-terminal fragment (residues 11–13) of alpha-melanocyte-stimulating hormone (α-MSH). With a molecular weight of approximately 384.47 g/mol, KPV retains the core anti-inflammatory properties of parent melanocortin peptides while lacking the melanogenic activity associated with full-length α-MSH receptor binding.
In structural assays, the Proline residue introduces a rigid turn in the peptide backbone, conferring relative resistance to enzymatic cleavage by serum endopeptidases compared to linear peptides. Research indicates that KPV acts non-stereospecifically and interacts with intracellular targets via specialized membrane transporters, such as PepT1 (peptide transporter 1), expressed highly in intestinal epithelial cells. Understanding these biochemical characteristics is essential when planning cell culture, tissue culture, or animal model experiments using the PX1 Research catalog.
To ensure experimental accuracy and maintain sterile conditions during KPV 5mg reconstitution, follow this standardized laboratory protocol:
1. Sanitization: Clean the laminar flow hood or biosafety cabinet work surface with 70% isopropyl alcohol. Allow the lyophilized KPV vial and diluent—typically bacteriostatic water for research—to reach ambient temperature (20°C–25°C).
2. Vials Prep: Pop off the protective flip cap of the KPV vial and wipe the rubber septum with a sterile alcohol swab. Allow it to air-dry completely.
3. Diluent Transfer: Using a sterile syringe equipped with a 21G to 25G needle, draw the calculated volume of diluent (e.g., 2.0 mL for a 2.5 mg/mL concentration).
4. Infiltration: Insert the needle into the center of the rubber stopper at a slight angle. Direct the stream of diluent along the glass inner wall of the vial rather than shooting it directly onto the lyophilized peptide cake.
5. Dissolution: Gently invert or swirl the vial between your palms until the powder is fully dissolved. Do not shake or vortex vigorously, as high shear force can induce mechanical denaturation or aggregation of peptide chains.
6. Inspection: Inspect the solution under bright light for clarity, particulate matter, or incomplete dissolution. The final reconstituted solution must be completely clear.
Accurate dilution mapping is vital for dosing precision in preclinical protocols. The table below outlines standard diluent additions for a single 5mg KPV vial:
• 1.0 mL diluent added = 5.0 mg/mL stock concentration (500 µg per 0.1 mL) • 2.0 mL diluent added = 2.5 mg/mL stock concentration (250 µg per 0.1 mL) • 2.5 mL diluent added = 2.0 mg/mL stock concentration (200 µg per 0.1 mL) • 5.0 mL diluent added = 1.0 mg/mL stock concentration (100 µg per 0.1 mL)
When designing microfluidic or cell viability assays requiring micromolar (µM) concentrations, calculate working dilutions using the formula C1V1 = C2V2. A 2.5 mg/mL KPV solution corresponds to a molar concentration of approximately 6.5 mM. Refer to the PX1 Research knowledge base for detailed mathematical formulas applied in peptide research.
Selecting the appropriate diluent depends directly on the downstream application:
• Bacteriostatic Water (0.9% Benzyl Alcohol): Ideal for multi-dose stock vials intended for extended preclinical animal studies over 14 to 28 days. Benzyl alcohol acts as a preservative to inhibit microbial growth during repeated needle punctures.
• Sterile Normal Saline (0.9% NaCl): Preferred when conducting short-term in vivo parenteral administration where benzyl alcohol exposure must be avoided.
• Phosphate-Buffered Saline (PBS, pH 7.4): Essential for in vitro cell culture, organoid models, and intestinal epithelial transport studies, as PBS maintains physiological pH and osmolality without compromising cell viability.
For non-aqueous or specialized formulations, KPV demonstrates high solubility in aqueous buffers. Organic solvents like DMSO are rarely necessary unless co-formulating with lipophilic test compounds.
Lyophilized KPV 5mg vials exhibit superior long-term stability when stored unopened at -20°C to -80°C, protected from light and moisture. Under these conditions, the dry powder remains stable for up to 24 months without measurable loss of purity.
Once reconstituted, KPV stock solutions stored in bacteriostatic water are stable at 2°C to 8°C (refrigerated) for up to 28 days. For aqueous PBS or saline solutions without preservatives, use the liquid immediately or aliquot and freeze at -80°C to prevent degradation and contamination.
Avoid repeated freeze-thaw cycles. Freezing creates ice crystal lattices that can break peptide bonds and cause localized aggregation. Sub-aliquoting single-use volumes into sterile polypropylene microcentrifuge tubes prior to freezing ensures consistent experimental reproducibility.
In preclinical literature, KPV is heavily investigated for its role in modulating inflammatory signaling pathways, particularly in models of inflammatory bowel disease (IBD) and intestinal epithelial damage. Studies using dextran sulfate sodium (DSS) and trinitrobenzene sulfonic acid (TNBS)-induced colitis in rodents demonstrate that KPV reduces mucosal inflammation, downregulates pro-inflammatory cytokines (such as TNF-α, IL-1β, and IL-6), and preserves gut barrier integrity.
Mechanistically, KPV enters intestinal epithelial cells via the apical membrane transporter PepT1. Once inside the cytoplasm, KPV inhibits nuclear factor kappa B (NF-κB) activation by blocking the translocation of the p65 subunit into the nucleus. This downregulates transcription of inflammatory mediators without activating classical melanocortin receptors (MC1R-MC5R), minimizing systemic endocrine off-target effects. Scientists analyzing mucosal wound healing often pair KPV data with findings from our BPC-157 research overview.
Researchers evaluating mucosal repair and barrier integrity frequently compare KPV against other prominent research peptides in the same therapeutic class, such as BPC-157 5mg, Larazotide research profile, and the LL-37 antimicrobial peptide.
While BPC-157 5mg operates largely through nitric oxide pathway modulation, focal adhesion kinase signaling, and VEGFR2 up-regulation to promote angiogenesis and tissue repair, KPV acts directly via intracellular PepT1 transport to inhibit the NF-κB inflammatory cascade. On the other hand, Larazotide functions strictly as a tight-junction regulator by blocking zonulin-mediated receptor activation, preventing hyperpermeability without directly suppressing intracellular cytokine transcription. Finally, LL-37 serves primarily as a host-defense antimicrobial peptide that neutralizes lipopolysaccharides (LPS). Investigating these distinct mechanisms provides a comprehensive understanding of mucosal physiology in complex disease models.
At PX1 Research, every lot of KPV 5mg undergoes rigorous analytical verification to guarantee high-tier experimental repeatability for laboratory institutions. We do not rely on generic supplier certificates; every batch is independently tested in ISO 17025 accredited facilities within the USA.
Our comprehensive quality control protocol includes:
• Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity levels consistently exceed 98.0%, verifying the absence of truncated sequences or chemical impurities.
• Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass (384.47 g/mol) and identity.
• Bacterial Endotoxin Testing (LAL Assay): Verifies endotoxin levels remain strictly under <0.5 EU/mg, protecting sensitive primary cell cultures and in vivo models from pyrogenic responses.
• Lot Traceability and COAs: Every single vial is linked to a lot-specific Certificate of Analysis downloadable directly by laboratory managers.
PX1 Research caters directly to universities, biotechnology companies, and private research laboratories requiring reliable supply chains and consistent compound quality. All compounds are manufactured in US-based GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona.
Orders placed Monday through Friday before 12:00 PM PST feature same-day dispatch to minimize transit delays. Principal investigators and procurement officers interested in bulk quantities or institutional accounts can apply for wholesale peptide accounts to secure dedicated account management, tiered pricing structure, and scheduled batch reservations.
How do you perform a standard kpv 5mg reconstitution in the laboratory?
To perform kpv 5mg reconstitution, sanitize the vial septum with 70% isopropyl alcohol, then slowly inject 2.0 mL of bacteriostatic water along the inner glass wall using a sterile syringe. Gently swirl the vial until the lyophilized powder completely dissolves into a clear 2.5 mg/mL solution.
What diluent volume yields a 1 mg/mL concentration for KPV 5mg?
Adding 5.0 mL of bacteriostatic water or sterile saline to a KPV 5mg vial yields a stock concentration of 1.0 mg/mL (100 µg per 0.1 mL).
Can KPV 5mg be reconstituted in Phosphate-Buffered Saline (PBS)?
Yes, sterile PBS (pH 7.4) is an ideal diluent for KPV when preparing solutions for in vitro cell culture, intestinal organoid assays, or immediate in vivo administration.
Why should KPV solutions be swirled rather than vortexed during reconstitution?
Vortexing or vigorous shaking introduces shear stress that can disrupt peptide bonds, induce mechanical denaturation, or form protein aggregates, compromising the integrity of the compound.
How long does reconstituted KPV 5mg remain stable in cold storage?
Reconstituted KPV in bacteriostatic water remains stable at 2°C to 8°C for up to 28 days. For unpreserved solutions (PBS or plain water), aliquot and freeze at -80°C immediately after reconstitution.
What is the primary cellular transporter involved in KPV cellular uptake?
Preclinical studies demonstrate that KPV is transported across apical cell membranes into the cytoplasm via PepT1 (peptide transporter 1), which is highly expressed in intestinal epithelial cells.
Is KPV derived from a larger peptide sequence?
Yes, KPV is a tripeptide representing the C-terminal amino acid sequence (residues 11–13) of alpha-melanocyte-stimulating hormone (α-MSH).
What purity level does PX1 Research guarantee for KPV 5mg?
PX1 Research guarantees a minimum purity of >98.0% for KPV 5mg, verified by RP-HPLC and mass spectrometry on every lot.
Are PX1 Research KPV 5mg vials tested for bacterial endotoxins?
Yes, every batch undergoes Limulus Amebocyte Lysate (LAL) endotoxin testing to ensure levels remain below <0.5 EU/mg, suitable for sensitive preclinical research.
Where does PX1 Research ship KPV 5mg orders from?
All orders are dispatched directly from our USA distribution facilities in California and Arizona, with same-day shipping available for orders placed before 12:00 PM PST Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.